Bookmark and Share
BioAssay: AID 588785

Late stage assay provider results from the probe development effort to identify inhibitors of pPAFAH: LC-MS/MS-based biochemical ABPP-MudPIT assay to determine selectivity of test compounds in the mouse brain membrane proteome

Name: Late stage assay provider results from the probe development effort to identify inhibitors of pPAFAH: LC-MS/MS-based biochemical ABPP-MudPIT assay to determine selectivity of test compounds in the mouse brain membrane proteome. ..more
_
   
 Tested Compounds
 Tested Compounds
All(1)
 
 
Active(1)
 
 
 Tested Substances
 Tested Substances
All(1)
 
 
Active(1)
 
 
AID: 588785
Data Source: The Scripps Research Institute Molecular Screening Center (pPAFAH_INH_LCMS_MEM)
BioAssay Type: Panel
Depositor Category: NIH Molecular Libraries Probe Production Network, Assay Provider
BioAssay Version:
Deposit Date: 2011-11-12
Hold-until Date: 2012-05-31
Modify Date: 2012-05-31

Data Table ( Complete ):           Active    All
BioActive Compound: 1
Depositor Specified Assays
Show more
AIDNameTypeProbeComment
463082Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH)screening Primary screen (pPAFAH inhibitors in singlicate)
463092Summary of probe development efforts to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH)summary1 Summary (pPAFAH inhibitors)
463230Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH; PLA2G7)screening Confirmation screen (pPAFAH inhibitors in triplicate)
588474Late stage assay provider results from the probe development effort to identify inhibitors of plasma platelet activating factor acetylhydrolase (pPAFAH): fluorescence-based biochemical gel-based competitive Activity-Based Protein Profiling (ABPP) inhibition of pPAFAHother ABPP Screen (pPAFAH inhibitors in singlicate)
588770Late stage assay provider results from the probe development effort to identify inhibitors of pPAFAH: fluorescence-based dose-response biochemical gel-based competitive Activity-Based Protein Profiling (ABPP) assay for SAR compoundsconfirmatory ABBP Screen (3XIC50; pPAFAH INH; SAR compounds)
588769Late stage assay provider results from the probe development effort to identify inhibitors of plasma platelet activating factor acetylhydrolase (pPAFAH): fluorescence-based dose response biochemical gel-based competitive Activity-Based Protein Profiling (ABPP) assay for HTS compoundsconfirmatory ABPP Screen (3XIC50; pPAFAH INH; HTS compounds)
588774Late stage assay provider results from the probe development effort to identify inhibitors of plasma platelet activating factor acetylhydrolase (pPAFAH): fluorescence-based biochemical gel-based competitive Activity-Based Protein Profiling (ABPP) inhibition and selectivity of SAR compounds in a complex proteomeother ABPP Screen (Inhibition and selectivity; SAR compounds)
588766Late stage assay provider results from the probe development effort to identify inhibitors of plasma platelet activating factor acetylhydrolase (pPAFAH): fluorescence-based dose response biochemical gel-based competitive Activity-Based Protein Profiling (ABPP) inhibition of human pPAFAHconfirmatory Cytox assay (5XCC50; 293T cells)
588773Late stage assay provider results from the probe development effort to identify inhibitors of plasma platelet activating factor acetylhydrolase (pPAFAH): fluorescence-based biochemical gel-based competitive Activity-Based Protein Profiling (ABPP) inhibition and selectivity of HTS compounds in a complex proteomeother ABPP Screen (Inhibition and selectivity; HTS compounds)
588767Late stage assay provider results from the probe development effort to identify inhibitors of plasma platelet activating factor acetylhydrolase (pPAFAH): fluorescence-based biochemical gel-based competitive Activity-Based Protein Profiling (ABPP) inhibition of PAFAH2other ABPP Screen (PAFAH2 Counterscreen)
588817Late stage assay provider results from the probe development effort to identify inhibitors of pPAFAH: fluorescence-based biochemical gel-based competitive Activity-Based Protein Profiling (ABPP) inhibition of pPAFAH in situother
588823Late stage assay provider results from the probe development effort to identify inhibitors of pPAFAH: fluorescence-based biochemical gel-based competitive Activity-Based Protein Profiling (ABPP) inhibition of pPAFAH and selectivity analysis in vivoother
Description:
Source (MLPCN Center Name): The Scripps Research Institute Molecular Screening Center (SRIMSC)
Center Affiliation: The Scripps Research Institute (TSRI)
Assay Providers: Brian Bahnson (Univ. of Delaware); Benjamin Cravatt, (TSRI)
Network: Molecular Libraries Probe Production Centers Network (MLPCN)
Grant Proposal Number: 1R01HL084366
Grant Proposal PI: Brian Bahnson
External Assay ID: pPAFAH_INH_LCMS_MEM

Name: Late stage assay provider results from the probe development effort to identify inhibitors of pPAFAH: LC-MS/MS-based biochemical ABPP-MudPIT assay to determine selectivity of test compounds in the mouse brain membrane proteome.

Description:

This project aims to develop specific inhibitors of plasma platelet activating factor acetylhydrolase (pPAFAH), and three associated members of the serine hydrolase family of enzymes-PAFAH2, PAFAH1b2, and PAFAH1b3. pPAFAH, an enzyme linked to the inflammatory pathways involved in atherosclerosis, asthma, anaphylactic shock, and other allergic reactions (1,2), is a lipoprotein-associated group VIIA phospholipase A2 that reduces the levels of the signaling molecule platelet activating factor (PAF) (3,4), a potent pro-inflammatory phospholipid signaling molecule (5), and other pro-inflammatory agents, such as oxidized phospholipids, through hydrolysis. A large number of studies have been published over the years since pPAFAH was first discovered linking an increase in pPAFAH concentration and/or activity to an increased risk of various cardiovascular diseases (6,7). The biological function of pPAFAH in the development of coronary heart diseases (CHD) is controversial, with both anti- and pro-inflammatory roles attributed to it (8,9). Dr. Bahnson and colleagues recently reported the first high-resolution crystal structure of the pPAFAH enzyme (10), and would like to expand their studies to co-crystallize pPAFAH with substrate-mimetic inhibitors to further define the active site and substrate specificity of pPAFAH. While one selective pPAFAH inhibitor has been reported (11), its properties are not suitable for the proposed studies. Given the complex biology of the pPAFAH enzymes, a complete characterization of their patho/physiological roles in lipid metabolism is necessary to maximize the success of therapeutic intervention. Towards this goal, development of selective inhibitors would significantly advance our understanding of these enzymes' substrate specificity and contribution to inflammatory disease processes including atherosclerosis, asthma, and rheumatoid arthritis. Pan-PAFAH inhibitors might be of heightened therapeutic value.

References:

1. Karasawa, K., Harada, A., Satoh, N., Inoue, K., and Setaka, M. (2003) Plasma platelet activating factor-acetylhydrolase (PAF-AH), Prog Lipid Res 42, 93-114.
2. Leitinger, N. (2005) Oxidized phospholipids as triggers of inflammation in atherosclerosis, Molecular Nutrition & Food Research 49, 1063-1071.
3. Blank, M. L., Lee, T., Fitzgerald, V., and Snyder, F. (1981) A specific acetylhydrolase for 1-alkyl-2- acetyl-sn-glycero-3-phosphocholine (a hypotensive and platelet-activating lipid), J Biol Chem 256, 175-178.
4. Farr, R. S., Cox, C. P., Wardlow, M. L., and Jorgensen, R. (1980) Preliminary studies of an acid labile factor (ALF) in human sera that inactivates platelet-activating factor (PAF), Clin Immunol Immunopathol 15, 318-330.
5. Zimmerman, G. A., McIntyre, T. M., Prescott, S. M., and Stafforini, D. M. (2002) The plateletactivating factor signaling system and its regulators in syndromes of inflammation and thrombosis, Crit Care Med 30, S294-301.
6. Anderson, J. L. (2008) Lipoprotein-associated phospholipase A2: an independent predictor of coronary artery disease events in primary and secondary prevention, Am J Cardiol 101, 23F-33F.
7. Sudhir, K. (2005) Clinical review: Lipoprotein-associated phospholipase A2, a novel inflammatory biomarker and independent risk predictor for cardiovascular disease, J Clin Endocrinol Metab 90, 3100-3105.
8. Wilensky, R. L., and Macphee, C. H. (2009) Lipoprotein-associated phospholipase A(2) and atherosclerosis, Curr Opin Lipidol 20, 415-420.
9. Karabina, S. A., and Ninio, E. (2006) Plasma PAF-acetylhydrolase: an unfulfilled promise?, Biochim Biophys Acta 1761, 1351-1358.
10. Samanta, U., and Bahnson, B. J. (2008) Crystal structure of human plasma platelet-activating factor acetylhydrolase: structural implication to lipoprotein binding and catalysis, J Biol Chem 283, 31617-31624.
11. Blackie, J. A., Bloomer, J. C., Brown, M. J. B., Cheng, H. Y., Hammond, B., Hickey, D. M. B., Ife, R. J., Leach, C. A., Lewis, V. A., Macphee, C. H., Milliner, K. J., Moores, K. E., Pinto, I. L., Smith, S. A., Stansfield, I. G., Stanway, S. J., Taylor, M. A., and Theobald, C. J. (2003) The identification of clinical candidate SB-480848: A potent inhibitor of lipoprotein-associated phospholipase A(2), Bioorganic & Medicinal Chemistry Letters 13, 1067-1070.

Keywords:

late stage, late stage AID, powders, assay provider, low throughput, secondary, PLA2G7, pPAFAH, serine hydrolase, platelet activating factor acetylhydrolase, inflammation, atherosclerosis, fluorescence, competitive activity-based protein profiling, ABPP, liquid chromatography, LC, tandem mass spectrometry, MS/MS, multidimensional protein identification technology, MudPIT, ABPP-MudPIT, inhibitor, selectivity, Scripps, The Scripps Research Institute Molecular Screening Center, SRIMSC, Molecular Libraries Probe Production Centers Network, MLPCN
Panel Information
Targets
    Data Table(Active)    Data Table(All)Show more
PID§NameSubstancePanel TargetsDescriptionAdditional Information
ActiveInactive
1Pla2g7 (pPAFAH)1platelet-activating factor acetylhydrolase [Mus musculus] [gi:31980752]
Taxonomy id: 10090
Gene id: 27226
2Magl1monoglyceride lipase isoform d [Mus musculus] [gi:261878511]
Taxonomy id: 10090
Gene id: 23945
3Faah1fatty acid amide hydrolase [Mus musculus] [gi:123253900]
Taxonomy id: 10090
Gene id: 14073
4Esd1S-formylglutathione hydrolase [Mus musculus] [gi:13937355]
Taxonomy id: 10090
Gene id: 13885
5Nceh11neutral cholesterol ester hydrolase 1 [Mus musculus] [gi:30520239]
Taxonomy id: 10090
Gene id: 320024
6Fasn1fatty acid synthase [Mus musculus] [gi:93102409]
Taxonomy id: 10090
Gene id: 14104
7Abhd61monoacylglycerol lipase ABHD6 [Mus musculus] [gi:31560264]
Taxonomy id: 10090
Gene id: 66082
8Abhd121monoacylglycerol lipase ABHD12 [Mus musculus] [gi:159110817]
Taxonomy id: 10090
Gene id: 76192
9Prepl1prolyl endopeptidase-like isoform a [Mus musculus] [gi:254939518]
Taxonomy id: 10090
Gene id: 213760
10Prep1prolyl endopeptidase [Mus musculus] [gi:6755152]
Taxonomy id: 10090
Gene id: 19072
11Acot21acyl-coenzyme A thioesterase 2, mitochondrial precursor [Mus musculus] [gi:238624114]
Taxonomy id: 10090
Gene id: 171210
12Abhd101abhydrolase domain-containing protein 10, mitochondrial precursor [Mus musculus] [gi:269784760]
Taxonomy id: 10090
Gene id: 213012
13Pnpla81calcium-independent phospholipase A2-gamma [Mus musculus] [gi:118130807]
Taxonomy id: 10090
Gene id: 67452
14Acot11acyl-coenzyme A thioesterase 1 [Mus musculus] [gi:6753550]
Taxonomy id: 10090
Gene id: 26897
15Lypla21acyl-protein thioesterase 2 [Mus musculus] [gi:7242156]
Taxonomy id: 10090
Gene id: 26394
16Bat51abhydrolase domain-containing protein 16A [Mus musculus] [gi:30519896]
Taxonomy id: 10090
Gene id: 193742
17Ache1acetylcholinesterase precursor [Mus musculus] [gi:13928664]
Taxonomy id: 10090
Gene id: 11423
18Pafah1b21platelet-activating factor acetylhydrolase IB subunit beta [Mus musculus] [gi:40254624]
Taxonomy id: 10090
Gene id: 18475
19Lyplal11lysophospholipase-like protein 1 [Mus musculus] [gi:227496223]
Taxonomy id: 10090
Gene id: 226791
20Pme11protein phosphatase methylesterase 1 [Mus musculus] [gi:30794138]
Taxonomy id: 10090
Gene id: 72590
21Fam108b11abhydrolase domain-containing protein FAM108B1 precursor [Mus musculus] [gi:38142456]
Taxonomy id: 10090
Gene id: 226016
22Apeh1Acylpeptide hydrolase [Mus musculus] [gi:19343726]
Taxonomy id: 10090
Gene id: 235606
23Abhd31abhydrolase domain-containing protein 3 [Mus musculus] [gi:19527360]
Taxonomy id: 10090
Gene id: 106861
24Abhd111abhydrolase domain-containing protein 11 isoform 1 [Mus musculus] [gi:21644577]
Taxonomy id: 10090
Gene id: 68758
25Abhd41abhydrolase domain-containing protein 4 isoform 1 [Mus musculus] [gi:326937491]
Taxonomy id: 10090
Gene id: 105501
26Pla2g151group XV phospholipase A2 precursor [Mus musculus] [gi:19527008]
Taxonomy id: 10090
Gene id: 192654
27Fam108a1abhydrolase domain-containing protein FAM108A precursor [Mus musculus] [gi:21703840]
Taxonomy id: 10090
Gene id: 216169
28Fam108c11abhydrolase domain-containing protein FAM108C1 [Mus musculus] [gi:158186616]
Taxonomy id: 10090
Gene id: 70178
29Rbbp91putative hydrolase RBBP9 [Mus musculus] [gi:86439977]
Taxonomy id: 10090
Gene id: 26450
30Lactb1serine beta-lactamase-like protein LACTB, mitochondrial precursor [Mus musculus] [gi:13507666]
Taxonomy id: 10090
Gene id: 80907
31Acot71cytosolic acyl coenzyme A thioester hydrolase isoform 1 [Mus musculus] [gi:225690616]
Taxonomy id: 10090
Gene id: 70025
32Pnpla61neuropathy target esterase [Mus musculus] [gi:170763472]
Taxonomy id: 10090
Gene id: 50767
33Dpp91dipeptidyl peptidase 9 [Mus musculus] [gi:255003757]
Taxonomy id: 10090
Gene id: 224897
34Tpp21Tpp2 protein [Mus musculus] [gi:37194903]
Taxonomy id: 10090
Gene id: 22019
35Pafah1b31platelet-activating factor acetylhydrolase IB subunit gamma [Mus musculus] [gi:6679201]
Taxonomy id: 10090
Gene id: 18476
36Dpp81dipeptidyl peptidase 8 [Mus musculus] [gi:31542571]
Taxonomy id: 10090
Gene id: 74388
37Lypla11acyl-protein thioesterase 1 [Mus musculus] [gi:6678760]
Taxonomy id: 10090
Gene id: 18777
38Lipe1hormone-sensitive lipase isoform 2 [Mus musculus] [gi:87239972]
Taxonomy id: 10090
Gene id: 16890
39Es11liver carboxylesterase N precursor [Mus musculus] [gi:247269929]
Taxonomy id: 10090
Gene id: 13884
40Acot31acyl-coenzyme A thioesterase 3 [Mus musculus] [gi:19527406]
Taxonomy id: 10090
Gene id: 171281
41Prcp1lysosomal Pro-X carboxypeptidase precursor [Mus musculus] [gi:33469015]
Taxonomy id: 10090
Gene id: 72461
42Parl1presenilins-associated rhomboid-like protein, mitochondrial precursor [Mus musculus] [gi:54261813]
Taxonomy id: 10090
Gene id: 381038
43Acot61acyl-coenzyme A thioesterase 6 [Mus musculus] [gi:110626167]
Taxonomy id: 10090
Gene id: 217700

§ Panel component ID.
Protocol
Assay Overview:

The purpose of this assay is to determine the selectivity profile of powder samples of test compounds in a mouse brain membrane proteome by activity-based protein profiling (ABPP) in combination with the multidimensional protein identification technology (MudPIT) liquid chromatography tandem mass spectrometry (LC-M/MS) analysis platform. In this assay, paired complex proteome samples are treated with test compound or DMSO, followed by reaction with the serine hydrolase specific activity-based fluorophosphonate-biotin (FP-biotin) affinity probe. Biotinylated proteins are enriched, trypsinized, and analyzed by MudPIT. Inhibition of target and anti-target activity is quantified by comparing spectra counts for a series of serine hydrolases between the test compound- and DMSO-treated samples. As designed, compounds that act as inhibitors will block FP-biotin labeling, reducing enrichment in the inhibitor-treated sample relative to the DMSO-treated sample, thus giving a smaller spectra count ratio (test compound/DMSO) for each protein. Proteins not targeted by inhibitors would be expected to have a ratio of 1.

Protocol Summary:

Sample Preparation: Paired aliquots of mouse brain membrane proteome (1 mL of 1 mg/mL in 50 mM Tris pH 8.0 [Tris] buffer) were treated with either 1 uM test compound (20 uL of a 50x stock in DMSO) or DMSO for 30 minutes at 37 C. Each reaction was labeled with 5 uM of FP-biotin (5 uL of a 50x stock in DMSO) for 2 hours at 25 C. TritonX100 was added to 1% final concentration (v/v), and the proteomes were desalted over PD-10 desalting columns (GE Healthcare). SDS was added to the eluate to give 0.5% final concentration, and the samples heated to 90 C for 8 minutes. FP-labeled proteins were enriched with streptavidin beads (100 uL of 50% slurry; 25 C, 1 hour, 8.5 mL total volume Tris). Following enrichment, the beads were washed with 1% SDS in Tris (2x), 6 M Urea in Tris (2x), and Tris (2x), and then resuspended in 8 M urea, reduced with TCEP (10 mM) for 25 minutes at 25 C, and alkylated with iodoacetamide (12.5 mM) for 25 minutes at 25 C in the dark. The urea concentration was reduced to 2 M with Tris, and on-bead digestions were performed for 12 hours at 37 C with sequence-grade modified trypsin (Promega; 2 ug) in the presence of 2 mM CaCl2. Peptide samples were acidified to a final concentration of 5% (v/v) formic acid, pressure-loaded on to a biphasic (strong cation exchange/reversed phase) MudPIT capillary column and analyzed as described below. A total of 3 to 4 biological replicates were prepared and analyzed for each experiment.

LC-MS/MS analysis: Digested and acidified peptide mixtures were analyzed by two-dimensional liquid chromatography/tandem mass spectrometry (MudPIT) using an Agilent 1200-series quaternary pump and Thermo Scientific LTQ ion trap mass spectrometer. Peptides were eluted in a 5-step MudPIT experiment using 0%, 25%, 50%, 80%, and 100% salt bumps of 500 mM aqueous ammonium acetate, with chromatographic elution following each salt pulse accomplished using an increasing gradient of aqueous acetonitrile containing 0.1% formic acid over 125 minutes. Data were collected in data-dependent acquisition mode with dynamic exclusion turned on (90 s, repeat of 1). Specifically, one full MS (MS1) scan (400-1800 m/z) was followed by 7 MS2 scans of the most abundant ions. The MS2 spectra data were extracted from the raw file using RAW Xtractor (version 1.9.1; publically available at http://fields.scripps.edu/downloads.php). MS2 spectra data were searched using the PROLUCID algorithm (publically available at http://fields.scripps.edu/downloads.php) against the latest version of the mouse UniProt database concatenated with the reversed database for assessment of false-discovery rates. PROLUCID searches allowed for variable oxidation of methionine (+16), static modification of cysteine (+57 due to alkylation), and no enzyme specificity. The resulting MS2 spectra matches were assembled into protein identifications and filtered using DTASelect (version 2.0.41) using the -trypstat and --modstat options, which apply different statistical models for the analysis of tryptic, half-tryptic, non-tryptic, and modified peptides. DTASelect 2.0 uses a quadratic discriminant analysis to maintain a user-defined false positive hit rate (as determined by number of hits against the reversed database) below 1% at the peptide level. Spectra count abundance ratios (test_compound/DMSO) were calculated for all serine hydrolases with an average of 10 or more spectra counts in the DMSO control samples.

Ratio = Average_Spectra_Counts_Test_Compound / Average_Spectra_Counts_DMSO_Control

Where:

Average_Spectra_Counts_Test_Compound is the average number of spectra counts for a given serine hydrolase across all test compound-treated samples.
Average_Spectra_Counts_DMSO_Control is the average number of spectra counts for a given serine hydrolase across all DMSO control samples.

PubChem Activity Outcome and Score:

The following applies to each panel in this assay:

A compound was considered active for a particular target/anti-target with an abundance ratio of less than or equal to 0.5. A compound was considered inactive for a specified target/anti-target with an abundance ratio of greater than 0.5.

Overall Outcome and Score:

A compound was considered active if it was active for pPAFAH (aka Pla2g7) and active for fewer than 2 serine hydrolase anti-targets. A compound was considered inactive if it was inactive for pPAFAH (aka Pla2g7) and/or active for 2 or more serine hydrolase anti-targets.

The PubChem Activity Score is assigned a value of 100 for active compounds, and 0 for inactive compounds.

The PubChem Activity Score range for active compounds is 100-100. There are no inactive compounds.

List of Reagents:

Mouse brain membrane proteome (provided by assay provider)
FP-biotin (provided by Assay Provider)
Tris-HCl (SigmaAldrich T5941)
Triton-X100 (Fisher AC21568-0010)
PD-10 desalting columns (GE Healthcare 17-0851-01)
SDS (SigmaAldrich L6026)
Urea (Fisher U15-3)
TCEP (SigmaAldrich 75259)
Iodoacetamide (iodoacetamide; SigmaAldrich I1149)
Trypsin (Promega V5111)
CaCl2 (SigmaAldrich C1016)
Streptavidin beads (Pierce 20349)
Formic acid (Fluka 06440)
Fused-silica (Agilent 160-2635-10)
Strong cation exchange (Phenomenex CH0-2257)
Aqua C18 (Phenomenex 04A-4299)
Acetonitrile (Fisher A955-4)
Millipore-filtered Water
Ammonium bicarbonate (Acros, AC37093-0010)
Comment
This assay was performed by the assay provider with powder samples of test compounds.
Categorized Comment
BAO: version: 1.4b1090

BAO: bioassay specification: assay stage: secondary: mmoa characterization

BAO: bioassay specification: assay biosafety level: bsl1

BAO: assay format: biochemical format: protein format: single protein format

BAO: bioassay specification: assay measurement type: endpoint assay

BAO: bioassay specification: assay readout content: assay readout method: regular screening

BAO: bioassay specification: assay readout content: content readout type: single readout

BAO: meta target: molecular target: protein target: enzyme: generic hydrolase

BAO: meta target detail: binding reporter specification: interaction: protein-small molecule

Result Definitions
Show more
TIDNameDescriptionPID§Panel TargetsHistogramTypeUnit
OutcomeThe BioAssay activity outcomeOutcome
ScoreThe BioAssay activity ranking scoreInteger
1Outcome [Pla2g7]One of Active, Inactive, or Not Tested.1platelet-activating factor acetylhydrolase [Mus musculus]Outcome
2Spectra Counts [1] [Pla2g7] (1μM**)Number of spectra counts for Pla2g7 in test compound treated sample, replicate 1.1Integer
3Spectra Counts [2] [Pla2g7] (1μM**)Number of spectra counts for Pla2g7 in test compound treated sample, replicate 2.1Integer
4Spectra Counts [3] [Pla2g7] (1μM**)Number of spectra counts for Pla2g7 in test compound treated sample, replicate 3.1Integer
5Spectra Counts [4] [Pla2g7] (1μM**)Number of spectra counts for Pla2g7 in test compound treated sample, replicate 4.1Integer
6Average Spectra Counts [Pla2g7] (1μM**)Average number of spectra counts for Pla2g7 in test compound treated samples.1Integer
7Standard Deviation [Pla2g7]Standard Deviation for the average number of spectra counts for Pla2g7 in test compound treated samples.1Float
8Spectra Counts [1] [DMSO control, Pla2g7]Number of spectra counts for Pla2g7 in DMSO control sample, replicate 1.1Integer
9Spectra Counts [2] [DMSO control, Pla2g7]Number of spectra counts for Pla2g7 in DMSO control sample, replicate 2.1Integer
10Spectra Counts [3] [DMSO control, Pla2g7]Number of spectra counts for Pla2g7 in DMSO control sample, replicate 3.1Integer
11Average Spectra Counts [DMSO control, Pla2g7]Average number of spectra counts for Pla2g7 in DMSO control samples.1Integer
12Standard Deviation [DMSO control, Pla2g7]Standard deviation for the average number of spectra counts for Pla2g7 in DMSO control samples.1Float
13Ratio Average Spectra Counts [Pla2g7]Ratio of average number of spectra counts in test compound treated samples over DMSO control samples.1Floatratio
14Outcome [Magl]One of Active, Inactive, or Not Tested.2monoglyceride lipase isoform d [Mus musculus]Outcome
15Spectra Counts [1] [Magl] (1μM**)Number of spectra counts for Magl in test compound treated sample, replicate 1.2Integer
16Spectra Counts [2] [Magl] (1μM**)Number of spectra counts for Magl in test compound treated sample, replicate 2.2Integer
17Spectra Counts [3] [Magl] (1μM**)Number of spectra counts for Magl in test compound treated sample, replicate 3.2Integer
18Spectra Counts [4] [Magl] (1μM**)Number of spectra counts for Magl in test compound treated sample, replicate 4.2Integer
19Average Spectra Counts [Magl] (1μM**)Average number of spectra counts for Magl in test compound treated samples.2Integer
20Standard Deviation [Magl]Standard Deviation for the average number of spectra counts for Magl in test compound treated samples.2Float
21Spectra Counts [1] [DMSO control, Magl]Number of spectra counts for Magl in DMSO control sample, replicate 1.2Integer
22Spectra Counts [2] [DMSO control, Magl]Number of spectra counts for Magl in DMSO control sample, replicate 2.2Integer
23Spectra Counts [3] [DMSO control, Magl]Number of spectra counts for Magl in DMSO control sample, replicate 3.2Integer
24Average Spectra Counts [DMSO control, Magl]Average number of spectra counts for Magl in DMSO control samples.2Integer
25Standard Deviation [DMSO control, Magl]Standard deviation for the average number of spectra counts for Magl in DMSO control samples.2Float
26Ratio Average Spectra Counts [Magl]Ratio of average number of spectra counts in test compound treated samples over DMSO control samples.2Floatratio
27Outcome [Faah]One of Active, Inactive, or Not Tested.3fatty acid amide hydrolase [Mus musculus]Outcome
28Spectra Counts [1] [Faah] (1μM**)Number of spectra counts for Faah in test compound treated sample, replicate 1.3Integer
29Spectra Counts [2] [Faah] (1μM**)Number of spectra counts for Faah in test compound treated sample, replicate 2.3Integer
30Spectra Counts [3] [Faah] (1μM**)Number of spectra counts for Faah in test compound treated sample, replicate 3.3Integer
31Spectra Counts [4] [Faah] (1μM**)Number of spectra counts for Faah in test compound treated sample, replicate 4.3Integer
32Average Spectra Counts [Faah] (1μM**)Average number of spectra counts for Faah in test compound treated samples.3Integer
33Standard Deviation [Faah]Standard Deviation for the average number of spectra counts for Faah in test compound treated samples.3Float
34Spectra Counts [1] [DMSO control, Faah]Number of spectra counts for Faah in DMSO control sample, replicate 1.3Integer
35Spectra Counts [2] [DMSO control, Faah]Number of spectra counts for Faah in DMSO control sample, replicate 2.3Integer
36Spectra Counts [3] [DMSO control, Faah]Number of spectra counts for Faah in DMSO control sample, replicate 3.3Integer
37Average Spectra Counts [DMSO control, Faah]Average number of spectra counts for Faah in DMSO control samples.3Integer
38Standard Deviation [DMSO control, Faah]Standard deviation for the average number of spectra counts for Faah in DMSO control samples.3Float
39Ratio Average Spectra Counts [Faah]Ratio of average number of spectra counts in test compound treated samples over DMSO control samples.3Floatratio
40Outcome [Esd]One of Active, Inactive, or Not Tested.4S-formylglutathione hydrolase [Mus musculus]Outcome
41Spectra Counts [1] [Esd] (1μM**)Number of spectra counts for Esd in test compound treated sample, replicate 1.4Integer
42Spectra Counts [2] [Esd] (1μM**)Number of spectra counts for Esd in test compound treated sample, replicate 2.4Integer
43Spectra Counts [3] [Esd] (1μM**)Number of spectra counts for Esd in test compound treated sample, replicate 3.4Integer
44Spectra Counts [4] [Esd] (1μM**)Number of spectra counts for Esd in test compound treated sample, replicate 4.4Integer
45Average Spectra Counts [Esd] (1μM**)Average number of spectra counts for Esd in test compound treated samples.4Integer
46Standard Deviation [Esd]Standard Deviation for the average number of spectra counts for Esd in test compound treated samples.4Float
47Spectra Counts [1] [DMSO control, Esd]Number of spectra counts for Esd in DMSO control sample, replicate 1.4Integer
48Spectra Counts [2] [DMSO control, Esd]Number of spectra counts for Esd in DMSO control sample, replicate 2.4Integer
49Spectra Counts [3] [DMSO control, Esd]Number of spectra counts for Esd in DMSO control sample, replicate 3.4Integer
50Average Spectra Counts [DMSO control, Esd]Average number of spectra counts for Esd in DMSO control samples.4Integer
51Standard Deviation [DMSO control, Esd]Standard deviation for the average number of spectra counts for Esd in DMSO control samples.4Float
52Ratio Average Spectra Counts [Esd]Ratio of average number of spectra counts in test compound treated samples over DMSO control samples.4Floatratio
53Outcome [Nceh1]One of Active, Inactive, or Not Tested.5neutral cholesterol ester hydrolase 1 [Mus musculus]Outcome
54Spectra Counts [1] [Nceh1] (1μM**)Number of spectra counts for Nceh1 in test compound treated sample, replicate 1.5Integer
55Spectra Counts [2] [Nceh1] (1μM**)Number of spectra counts for Nceh1 in test compound treated sample, replicate 2.5Integer
56Spectra Counts [3] [Nceh1] (1μM**)Number of spectra counts for Nceh1 in test compound treated sample, replicate 3.5Integer
57Spectra Counts [4] [Nceh1] (1μM**)Number of spectra counts for Nceh1 in test compound treated sample, replicate 4.5Integer
58Average Spectra Counts [Nceh1] (1μM**)Average number of spectra counts for Nceh1 in test compound treated samples.5Integer
59Standard Deviation [Nceh1]Standard Deviation for the average number of spectra counts for Nceh1 in test compound treated samples.5Float
60Spectra Counts [1] [DMSO control, Nceh1]Number of spectra counts for Nceh1 in DMSO control sample, replicate 1.5Integer
61Spectra Counts [2] [DMSO control, Nceh1]Number of spectra counts for Nceh1 in DMSO control sample, replicate 2.5Integer
62Spectra Counts [3] [DMSO control, Nceh1]Number of spectra counts for Nceh1 in DMSO control sample, replicate 3.5Integer
63Average Spectra Counts [DMSO control, Nceh1]Average number of spectra counts for Nceh1 in DMSO control samples.5Integer
64Standard Deviation [DMSO control, Nceh1]Standard deviation for the average number of spectra counts for Nceh1 in DMSO control samples.5Float
65Ratio Average Spectra Counts [Nceh1]Ratio of average number of spectra counts in test compound treated samples over DMSO control samples.5Floatratio
66Outcome [Fasn]One of Active, Inactive, or Not Tested.6fatty acid synthase [Mus musculus]Outcome
67Spectra Counts [1] [Fasn] (1μM**)Number of spectra counts for Fasn in test compound treated sample, replicate 1.6Integer
68Spectra Counts [2] [Fasn] (1μM**)Number of spectra counts for Fasn in test compound treated sample, replicate 2.6Integer
69Spectra Counts [3] [Fasn] (1μM**)Number of spectra counts for Fasn in test compound treated sample, replicate 3.6Integer
70Spectra Counts [4] [Fasn] (1μM**)Number of spectra counts for Fasn in test compound treated sample, replicate 4.6Integer
71Average Spectra Counts [Fasn] (1μM**)Average number of spectra counts for Fasn in test compound treated samples.6Integer
72Standard Deviation [Fasn]Standard Deviation for the average number of spectra counts for Fasn in test compound treated samples.6Float
73Spectra Counts [1] [DMSO control, Fasn]Number of spectra counts for Fasn in DMSO control sample, replicate 1.6Integer
74Spectra Counts [2] [DMSO control, Fasn]Number of spectra counts for Fasn in DMSO control sample, replicate 2.6Integer
75Spectra Counts [3] [DMSO control, Fasn]Number of spectra counts for Fasn in DMSO control sample, replicate 3.6Integer
76Average Spectra Counts [DMSO control, Fasn]Average number of spectra counts for Fasn in DMSO control samples.6Integer
77Standard Deviation [DMSO control, Fasn]Standard deviation for the average number of spectra counts for Fasn in DMSO control samples.6Float
78Ratio Average Spectra Counts [Fasn]Ratio of average number of spectra counts in test compound treated samples over DMSO control samples.6Floatratio
79Outcome [Abdh6]One of Active, Inactive, or Not Tested.7monoacylglycerol lipase ABHD6 [Mus musculus]Outcome
80Spectra Counts [1] [Abdh6] (1μM**)Number of spectra counts for Abhd6 in test compound treated sample, replicate 1.7Integer
81Spectra Counts [2] [Abdh6] (1μM**)Number of spectra counts for Abhd6 in test compound treated sample, replicate 2.7Integer
82Spectra Counts [3] [Abdh6] (1μM**)Number of spectra counts for Abhd6 in test compound treated sample, replicate 3.7Integer
83Spectra Counts [4] [Abdh6] (1μM**)Number of spectra counts for Abhd6 in test compound treated sample, replicate 4.7Integer
84Average Spectra Counts [Abdh6] (1μM**)Average number of spectra counts for Abhd6 in test compound treated samples.7Integer
85Standard Deviation [Abdh6]Standard Deviation for the average number of spectra counts for Abhd6 in test compound treated samples.7Float
86Spectra Counts [1] [DMSO control, Abdh6]Number of spectra counts for Abhd6 in DMSO control sample, replicate 1.7Integer
87Spectra Counts [2] [DMSO control, Abdh6]Number of spectra counts for Abhd6 in DMSO control sample, replicate 2.7Integer
88Spectra Counts [3] [DMSO control, Abdh6]Number of spectra counts for Abhd6 in DMSO control sample, replicate 3.7Integer
89Average Spectra Counts [DMSO control, Abdh6]Average number of spectra counts for Abhd6 in DMSO control samples.7Integer
90Standard Deviation [DMSO control, Abdh6]Standard deviation for the average number of spectra counts for Abhd6 in DMSO control samples.7Float
91Ratio Average Spectra Counts [Abdh6]Ratio of average number of spectra counts in test compound treated samples over DMSO control samples.7Floatratio
92Outcome [Abdh12]One of Active, Inactive, or Not Tested.8monoacylglycerol lipase ABHD12 [Mus musculus]Outcome
93Spectra Counts [1] [Abdh12] (1μM**)Number of spectra counts for Abhd12 in test compound treated sample, replicate 1.8Integer
94Spectra Counts [2] [Abdh12] (1μM**)Number of spectra counts for Abhd12 in test compound treated sample, replicate 2.8Integer
95Spectra Counts [3] [Abdh12] (1μM**)Number of spectra counts for Abhd12 in test compound treated sample, replicate 3.8Integer
96Spectra Counts [4] [Abdh12] (1μM**)Number of spectra counts for Abhd12 in test compound treated sample, replicate 4.8Integer
97Average Spectra Counts [Abdh12] (1μM**)Average number of spectra counts for Abhd12 in test compound treated samples.8Integer
98Standard Deviation [Abdh12]Standard Deviation for the average number of spectra counts for Abhd12 in test compound treated samples.8Float
99Spectra Counts [1] [DMSO control, Abdh12]Number of spectra counts for Abhd12 in DMSO control sample, replicate 1.8Integer
100Spectra Counts [2] [DMSO control, Abdh12]Number of spectra counts for Abhd12 in DMSO control sample, replicate 2.8Integer
101Spectra Counts [3] [DMSO control, Abdh12]Number of spectra counts for Abhd12 in DMSO control sample, replicate 3.8Integer
102Average Spectra Counts [DMSO control, Abdh12]Average number of spectra counts for Abhd12 in DMSO control samples.8Integer
103Standard Deviation [DMSO control, Abdh12]Standard deviation for the average number of spectra counts for Abhd12 in DMSO control samples.8Float
104Ratio Average Spectra Counts [Abdh12]Ratio of average number of spectra counts in test compound treated samples over DMSO control samples.8Floatratio
105Outcome [Prepl]One of Active, Inactive, or Not Tested.9prolyl endopeptidase-like isoform a [Mus musculus]Outcome
106Spectra Counts [1] [Prepl] (1μM**)Number of spectra counts for Prepl in test compound treated sample, replicate 1.9Integer
107Spectra Counts [2] [Prepl] (1μM**)Number of spectra counts for Prepl in test compound treated sample, replicate 2.9Integer
108Spectra Counts [3] [Prepl] (1μM**)Number of spectra counts for Prepl in test compound treated sample, replicate 3.9Integer
109Spectra Counts [4] [Prepl] (1μM**)Number of spectra counts for Prepl in test compound treated sample, replicate 4.9Integer
110Average Spectra Counts [Prepl] (1μM**)Average number of spectra counts for Prepl in test compound treated samples.9Integer
111Standard Deviation [Prepl]Standard Deviation for the average number of spectra counts for Prepl in test compound treated samples.9Float
112Spectra Counts [1] [DMSO control, Prepl]Number of spectra counts for Prepl in DMSO control sample, replicate 1.9Integer
113Spectra Counts [2] [DMSO control, Prepl]Number of spectra counts for Prepl in DMSO control sample, replicate 2.9Integer
114Spectra Counts [3] [DMSO control, Prepl]Number of spectra counts for Prepl in DMSO control sample, replicate 3.9Integer
115Average Spectra Counts [DMSO control, Prepl]Average number of spectra counts for Prepl in DMSO control samples.9Integer
116Standard Deviation [DMSO control, Prepl]Standard deviation for the average number of spectra counts for Prepl in DMSO control samples.9Float
117Ratio Average Spectra Counts [Prepl]Ratio of average number of spectra counts in test compound treated samples over DMSO control samples.9Floatratio
118Outcome [Prep]One of Active, Inactive, or Not Tested.10prolyl endopeptidase [Mus musculus]Outcome
119Spectra Counts [1] [Prep] (1μM**)Number of spectra counts for Prep in test compound treated sample, replicate 1.10Integer
120Spectra Counts [2] [Prep] (1μM**)Number of spectra counts for Prep in test compound treated sample, replicate 2.10Integer
121Spectra Counts [3] [Prep] (1μM**)Number of spectra counts for Prep in test compound treated sample, replicate 3.10Integer
122Spectra Counts [4] [Prep] (1μM**)Number of spectra counts for Prep in test compound treated sample, replicate 4.10Integer
123Average Spectra Counts [Prep] (1μM**)Average number of spectra counts for Prep in test compound treated samples.10Integer
124Standard Deviation [Prep]Standard Deviation for the average number of spectra counts for Prep in test compound treated samples.10Float
125Spectra Counts [1] [DMSO control, Prep]Number of spectra counts for Prep in DMSO control sample, replicate 1.10Integer
126Spectra Counts [2] [DMSO control, Prep]Number of spectra counts for Prep in DMSO control sample, replicate 2.10Integer
127Spectra Counts [3] [DMSO control, Prep]Number of spectra counts for Prep in DMSO control sample, replicate 3.10Integer
128Average Spectra Counts [DMSO control, Prep]Average number of spectra counts for Prep in DMSO control samples.10Integer
129Standard Deviation [DMSO control, Prep]Standard deviation for the average number of spectra counts for Prep in DMSO control samples.10Float
130Ratio Average Spectra Counts [Prep]Ratio of average number of spectra counts in test compound treated samples over DMSO control samples.10Floatratio
131Outcome [Acot2]One of Active, Inactive, or Not Tested.11acyl-coenzyme A thioesterase 2, mitochondrial precursor [Mus musculus]Outcome
132Spectra Counts [1] [Acot2] (1μM**)Number of spectra counts for Acot2 in test compound treated sample, replicate 1.11Integer
133Spectra Counts [2] [Acot2] (1μM**)Number of spectra counts for Acot2 in test compound treated sample, replicate 2.11Integer
134Spectra Counts [3] [Acot2] (1μM**)Number of spectra counts for Acot2 in test compound treated sample, replicate 3.11Integer
135Spectra Counts [4] [Acot2] (1μM**)Number of spectra counts for Acot2 in test compound treated sample, replicate 4.11Integer
136Average Spectra Counts [Acot2] (1μM**)Average number of spectra counts for Acot2 in test compound treated samples.11Integer
137Standard Deviation [Acot2]Standard Deviation for the average number of spectra counts for Acot2 in test compound treated samples.11Float
138Spectra Counts [1] [DMSO control, Acot2]Number of spectra counts for Acot2 in DMSO control sample, replicate 1.11Integer
139Spectra Counts [2] [DMSO control, Acot2]Number of spectra counts for Acot2 in DMSO control sample, replicate 2.11Integer
140Spectra Counts [3] [DMSO control, Acot2]Number of spectra counts for Acot2 in DMSO control sample, replicate 3.11Integer
141Average Spectra Counts [DMSO control, Acot2]Average number of spectra counts for Acot2 in DMSO control samples.11Integer
142Standard Deviation [DMSO control, Acot2]Standard deviation for the average number of spectra counts for Acot2 in DMSO control samples.11Float
143Ratio Average Spectra Counts [Acot2]Ratio of average number of spectra counts in test compound treated samples over DMSO control samples.11Floatratio
144Outcome [Abdh10]One of Active, Inactive, or Not Tested.12abhydrolase domain-containing protein 10, mitochondrial precursor [Mus musculus]Outcome
145Spectra Counts [1] [Abdh10] (1μM**)Number of spectra counts for Abhd10 in test compound treated sample, replicate 1.12Integer
146Spectra Counts [2] [Abdh10] (1μM**)Number of spectra counts for Abhd10 in test compound treated sample, replicate 2.12Integer
147Spectra Counts [3] [Abdh10] (1μM**)Number of spectra counts for Abhd10 in test compound treated sample, replicate 3.12Integer
148Spectra Counts [4] [Abdh10] (1μM**)Number of spectra counts for Abhd10 in test compound treated sample, replicate 4.12Integer
149Average Spectra Counts [Abdh10] (1μM**)Average number of spectra counts for Abhd10 in test compound treated samples.12Integer
150Standard Deviation [Abdh10]Standard Deviation for the average number of spectra counts for Abhd10 in test compound treated samples.12Float
151Spectra Counts [1] [DMSO control, Abdh10]Number of spectra counts for Abhd10 in DMSO control sample, replicate 1.12Integer
152Spectra Counts [2] [DMSO control, Abdh10]Number of spectra counts for Abhd10 in DMSO control sample, replicate 2.12Integer
153Spectra Counts [3] [DMSO control, Abdh10]Number of spectra counts for Abhd10 in DMSO control sample, replicate 3.12Integer
154Average Spectra Counts [DMSO control, Abdh10]Average number of spectra counts for Abhd10 in DMSO control samples.12Integer
155Standard Deviation [DMSO control, Abdh10]Standard deviation for the average number of spectra counts for Abhd10 in DMSO control samples.12Float
156Ratio Average Spectra Counts [Abdh10]Ratio of average number of spectra counts in test compound treated samples over DMSO control samples.12Floatratio
157Outcome [Pnpla8]One of Active, Inactive, or Not Tested.13calcium-independent phospholipase A2-gamma [Mus musculus]Outcome
158Spectra Counts [1] [Pnpla8] (1μM**)Number of spectra counts for Pnpla8 in test compound treated sample, replicate 1.13Integer
159Spectra Counts [2] [Pnpla8] (1μM**)Number of spectra counts for Pnpla8 in test compound treated sample, replicate 2.13Integer
160Spectra Counts [3] [Pnpla8] (1μM**)Number of spectra counts for Pnpla8 in test compound treated sample, replicate 3.13Integer
161Spectra Counts [4] [Pnpla8] (1μM**)Number of spectra counts for Pnpla8 in test compound treated sample, replicate 4.13Integer
162Average Spectra Counts [Pnpla8] (1μM**)Average number of spectra counts for Pnpla8 in test compound treated samples.13Integer
163Standard Deviation [Pnpla8]Standard Deviation for the average number of spectra counts for Pnpla8 in test compound treated samples.13Float
164Spectra Counts [1] [DMSO control, Pnpla8]Number of spectra counts for Pnpla8 in DMSO control sample, replicate 1.13Integer
165Spectra Counts [2] [DMSO control, Pnpla8]Number of spectra counts for Pnpla8 in DMSO control sample, replicate 2.13Integer
166Spectra Counts [3] [DMSO control, Pnpla8]Number of spectra counts for Pnpla8 in DMSO control sample, replicate 3.13Integer
167Average Spectra Counts [DMSO control, Pnpla8]Average number of spectra counts for Pnpla8 in DMSO control samples.13Integer
168Standard Deviation [DMSO control, Pnpla8]Standard deviation for the average number of spectra counts for Pnpla8 in DMSO control samples.13Float
169Ratio Average Spectra Counts [Pnpla8]Ratio of average number of spectra counts in test compound treated samples over DMSO control samples.13Floatratio
170Outcome [Acot1]One of Active, Inactive, or Not Tested.14acyl-coenzyme A thioesterase 1 [Mus musculus]Outcome
171Spectra Counts [1] [Acot1] (1μM**)Number of spectra counts for Acot1 in test compound treated sample, replicate 1.14Integer
172Spectra Counts [2] [Acot1] (1μM**)Number of spectra counts for Acot1 in test compound treated sample, replicate 2.14Integer
173Spectra Counts [3] [Acot1] (1μM**)Number of spectra counts for Acot1 in test compound treated sample, replicate 3.14Integer
174Spectra Counts [4] [Acot1] (1μM**)Number of spectra counts for Acot1 in test compound treated sample, replicate 4.14Integer
175Average Spectra Counts [Acot1] (1μM**)Average number of spectra counts for Acot1 in test compound treated samples.14Integer
176Standard Deviation [Acot1]Standard Deviation for the average number of spectra counts for Acot1 in test compound treated samples.14Float
177Spectra Counts [1] [DMSO control, Acot1]Number of spectra counts for Acot1 in DMSO control sample, replicate 1.14Integer
178Spectra Counts [2] [DMSO control, Acot1]Number of spectra counts for Acot1 in DMSO control sample, replicate 2.14Integer
179Spectra Counts [3] [DMSO control, Acot1]Number of spectra counts for Acot1 in DMSO control sample, replicate 3.14Integer
180Average Spectra Counts [DMSO control, Acot1]Average number of spectra counts for Acot1 in DMSO control samples.14Integer
181Standard Deviation [DMSO control, Acot1]Standard deviation for the average number of spectra counts for Acot1 in DMSO control samples.14Float
182Ratio Average Spectra Counts [Acot1]Ratio of average number of spectra counts in test compound treated samples over DMSO control samples.14Floatratio
183Outcome [Lypla2]One of Active, Inactive, or Not Tested.15acyl-protein thioesterase 2 [Mus musculus]Outcome
184Spectra Counts [1] [Lypla2] (1μM**)Number of spectra counts for Lypla2 in test compound treated sample, replicate 1.15Integer
185Spectra Counts [2] [Lypla2] (1μM**)Number of spectra counts for Lypla2 in test compound treated sample, replicate 2.15Integer
186Spectra Counts [3] [Lypla2] (1μM**)Number of spectra counts for Lypla2 in test compound treated sample, replicate 3.15Integer
187Spectra Counts [4] [Lypla2] (1μM**)Number of spectra counts for Lypla2 in test compound treated sample, replicate 4.15Integer
188Average Spectra Counts [Lypla2] (1μM**)Average number of spectra counts for Lypla2 in test compound treated samples.15Integer
189Standard Deviation [Lypla2]Standard Deviation for the average number of spectra counts for Lypla2 in test compound treated samples.15Float
190Spectra Counts [1] [DMSO control, Lypla2]Number of spectra counts for Lypla2 in DMSO control sample, replicate 1.15Integer
191Spectra Counts [2] [DMSO control, Lypla2]Number of spectra counts for Lypla2 in DMSO control sample, replicate 2.15Integer
192Spectra Counts [3] [DMSO control, Lypla2]Number of spectra counts for Lypla2 in DMSO control sample, replicate 3.15Integer
193Average Spectra Counts [DMSO control, Lypla2]Average number of spectra counts for Lypla2 in DMSO control samples.15Integer
194Standard Deviation [DMSO control, Lypla2]Standard deviation for the average number of spectra counts for Lypla2 in DMSO control samples.15Float
195Ratio Average Spectra Counts [Lypla2]Ratio of average number of spectra counts in test compound treated samples over DMSO control samples.15Floatratio
196Outcome [Bat5]One of Active, Inactive, or Not Tested.16abhydrolase domain-containing protein 16A [Mus musculus]Outcome
197Spectra Counts [1] [Bat5] (1μM**)Number of spectra counts for Bat5 in test compound treated sample, replicate 1.16Integer
198Spectra Counts [2] [Bat5] (1μM**)Number of spectra counts for Bat5 in test compound treated sample, replicate 2.16Integer
199Spectra Counts [3] [Bat5] (1μM**)Number of spectra counts for Bat5 in test compound treated sample, replicate 3.16Integer
200Spectra Counts [4] [Bat5] (1μM**)Number of spectra counts for Bat5 in test compound treated sample, replicate 4.16Integer
201Average Spectra Counts [Bat5] (1μM**)Average number of spectra counts for Bat5 in test compound treated samples.16Integer
202Standard Deviation [Bat5]Standard Deviation for the average number of spectra counts for Bat5 in test compound treated samples.16Float
203Spectra Counts [1] [DMSO control, Bat5]Number of spectra counts for Bat5 in DMSO control sample, replicate 1.16Integer
204Spectra Counts [2] [DMSO control, Bat5]Number of spectra counts for Bat5 in DMSO control sample, replicate 2.16Integer
205Spectra Counts [3] [DMSO control, Bat5]Number of spectra counts for Bat5 in DMSO control sample, replicate 3.16Integer
206Average Spectra Counts [DMSO control, Bat5]Average number of spectra counts for Bat5 in DMSO control samples.16Integer
207Standard Deviation [DMSO control, Bat5]Standard deviation for the average number of spectra counts for Bat5 in DMSO control samples.16Float
208Ratio Average Spectra Counts [Bat5]Ratio of average number of spectra counts in test compound treated samples over DMSO control samples.16Floatratio
209Outcome [Ache]One of Active, Inactive, or Not Tested.17acetylcholinesterase precursor [Mus musculus]Outcome
210Spectra Counts [1] [Ache] (1μM**)Number of spectra counts for Ache in test compound treated sample, replicate 1.17Integer
211Spectra Counts [2] [Ache] (1μM**)Number of spectra counts for Ache in test compound treated sample, replicate 2.17Integer
212Spectra Counts [3] [Ache] (1μM**)Number of spectra counts for Ache in test compound treated sample, replicate 3.17Integer
213Spectra Counts [4] [Ache] (1μM**)Number of spectra counts for Ache in test compound treated sample, replicate 4.17Integer
214Average Spectra Counts [Ache] (1μM**)Average number of spectra counts for Ache in test compound treated samples.17Integer
215Standard Deviation [Ache]Standard Deviation for the average number of spectra counts for Ache in test compound treated samples.17Float
216Spectra Counts [1] [DMSO control, Ache]Number of spectra counts for Ache in DMSO control sample, replicate 1.17Integer
217Spectra Counts [2] [DMSO control, Ache]Number of spectra counts for Ache in DMSO control sample, replicate 2.17Integer
218Spectra Counts [3] [DMSO control, Ache]Number of spectra counts for Ache in DMSO control sample, replicate 3.17Integer
219Average Spectra Counts [DMSO control, Ache]Average number of spectra counts for Ache in DMSO control samples.17Integer
220Standard Deviation [DMSO control, Ache]Standard deviation for the average number of spectra counts for Ache in DMSO control samples.17Float
221Ratio Average Spectra Counts [Ache]Ratio of average number of spectra counts in test compound treated samples over DMSO control samples.17Floatratio
222Outcome [Pafah1b2]One of Active, Inactive, or Not Tested.18platelet-activating factor acetylhydrolase IB subunit beta [Mus musculus]Outcome
223Spectra Counts [1] [Pafah1b2] (1μM**)Number of spectra counts for Pafah1b2 in test compound treated sample, replicate 1.18Integer
224Spectra Counts [2] [Pafah1b2] (1μM**)Number of spectra counts for Pafah1b2 in test compound treated sample, replicate 2.18Integer
225Spectra Counts [3] [Pafah1b2] (1μM**)Number of spectra counts for Pafah1b2 in test compound treated sample, replicate 3.18Integer
226Spectra Counts [4] [Pafah1b2] (1μM**)Number of spectra counts for Pafah1b2 in test compound treated sample, replicate 4.18Integer
227Average Spectra Counts [Pafah1b2] (1μM**)Average number of spectra counts for Pafah1b2 in test compound treated samples.18Integer
228Standard Deviation [Pafah1b2]Standard Deviation for the average number of spectra counts for Pafah1b2 in test compound treated samples.18Float
229Spectra Counts [1] [DMSO control, Pafah1b2]Number of spectra counts for Pafah1b2 in DMSO control sample, replicate 1.18Integer
230Spectra Counts [2] [DMSO control, Pafah1b2]Number of spectra counts for Pafah1b2 in DMSO control sample, replicate 2.18Integer
231Spectra Counts [3] [DMSO control, Pafah1b2]Number of spectra counts for Pafah1b2 in DMSO control sample, replicate 3.18Integer
232Average Spectra Counts [DMSO control, Pafah1b2]Average number of spectra counts for Pafah1b2 in DMSO control samples.18Integer
233Standard Deviation [DMSO control, Pafah1b2]Standard deviation for the average number of spectra counts for Pafah1b2 in DMSO control samples.18Float
234Ratio Average Spectra Counts [Pafah1b2]Ratio of average number of spectra counts in test compound treated samples over DMSO control samples.18Floatratio
235Outcome [Lypla1]One of Active, Inactive, or Not Tested.19lysophospholipase-like protein 1 [Mus musculus]Outcome
236Spectra Counts [1] [Lypla1] (1μM**)Number of spectra counts for Lypla1 in test compound treated sample, replicate 1.19Integer
237Spectra Counts [2] [Lypla1] (1μM**)Number of spectra counts for Lypla1 in test compound treated sample, replicate 2.19Integer
238Spectra Counts [3] [Lypla1] (1μM**)Number of spectra counts for Lypla1 in test compound treated sample, replicate 3.19Integer
239Spectra Counts [4] [Lypla1] (1μM**)Number of spectra counts for Lypla1 in test compound treated sample, replicate 4.19Integer
240Average Spectra Counts [Lypla1] (1μM**)Average number of spectra counts for Lypla1 in test compound treated samples.19Integer
241Standard Deviation [Lypla1]Standard Deviation for the average number of spectra counts for Lypla1 in test compound treated samples.19Float
242Spectra Counts [1] [DMSO control, Lypla1]Number of spectra counts for Lypla1 in DMSO control sample, replicate 1.19Integer
243Spectra Counts [2] [DMSO control, Lypla1]Number of spectra counts for Lypla1 in DMSO control sample, replicate 2.19Integer
244Spectra Counts [3] [DMSO control, Lypla1]Number of spectra counts for Lypla1 in DMSO control sample, replicate 3.19Integer
245Average Spectra Counts [DMSO control, Lypla1]Average number of spectra counts for Lypla1 in DMSO control samples.19Integer
246Standard Deviation [DMSO control, Lypla1]Standard deviation for the average number of spectra counts for Lypla1 in DMSO control samples.19Float
247Ratio Average Spectra Counts [Lypla1]Ratio of average number of spectra counts in test compound treated samples over DMSO control samples.19Floatratio
248Outcome [Pme1]One of Active, Inactive, or Not Tested.20protein phosphatase methylesterase 1 [Mus musculus]Outcome
249Spectra Counts [1] [Pme1] (1μM**)Number of spectra counts for Pme1 in test compound treated sample, replicate 1.20Integer
250Spectra Counts [2] [Pme1] (1μM**)Number of spectra counts for Pme1 in test compound treated sample, replicate 2.20Integer
251Spectra Counts [3] [Pme1] (1μM**)Number of spectra counts for Pme1 in test compound treated sample, replicate 3.20Integer
252Spectra Counts [4] [Pme1] (1μM**)Number of spectra counts for Pme1 in test compound treated sample, replicate 4.20Integer
253Average Spectra Counts [Pme1] (1μM**)Average number of spectra counts for Pme1 in test compound treated samples.20Integer
254Standard Deviation [Pme1]Standard Deviation for the average number of spectra counts for Pme1 in test compound treated samples.20Float
255Spectra Counts [1] [DMSO control, Pme1]Number of spectra counts for Pme1 in DMSO control sample, replicate 1.20Integer
256Spectra Counts [2] [DMSO control, Pme1]Number of spectra counts for Pme1 in DMSO control sample, replicate 2.20Integer
257Spectra Counts [3] [DMSO control, Pme1]Number of spectra counts for Pme1 in DMSO control sample, replicate 3.20Integer
258Average Spectra Counts [DMSO control, Pme1]Average number of spectra counts for Pme1 in DMSO control samples.20Integer
259Standard Deviation [DMSO control, Pme1]Standard deviation for the average number of spectra counts for Pme1 in DMSO control samples.20Float
260Ratio Average Spectra Counts [Pme1]Ratio of average number of spectra counts in test compound treated samples over DMSO control samples.20Floatratio
261Outcome [Fam108b1]One of Active, Inactive, or Not Tested.21abhydrolase domain-containing protein FAM108B1 precursor [Mus musculus]Outcome
262Spectra Counts [1] [Fam108b1] (1μM**)Number of spectra counts for Fam108b1 in test compound treated sample, replicate 1.21Integer
263Spectra Counts [2] [Fam108b1] (1μM**)Number of spectra counts for Fam108b1 in test compound treated sample, replicate 2.21Integer
264Spectra Counts [3] [Fam108b1] (1μM**)Number of spectra counts for Fam108b1 in test compound treated sample, replicate 3.21Integer
265Spectra Counts [4] [Fam108b1] (1μM**)Number of spectra counts for Fam108b1 in test compound treated sample, replicate 4.21Integer
266Average Spectra Counts [Fam108b1] (1μM**)Average number of spectra counts for Fam108b1 in test compound treated samples.21Integer
267Standard Deviation [Fam108b1]Standard Deviation for the average number of spectra counts for Fam108b1 in test compound treated samples.21Float
268Spectra Counts [1] [DMSO control, Fam108b1]Number of spectra counts for Fam108b1 in DMSO control sample, replicate 1.21Integer
269Spectra Counts [2] [DMSO control, Fam108b1]Number of spectra counts for Fam108b1 in DMSO control sample, replicate 2.21Integer
270Spectra Counts [3] [DMSO control, Fam108b1]Number of spectra counts for Fam108b1 in DMSO control sample, replicate 3.21Integer
271Average Spectra Counts [DMSO control, Fam108b1]Average number of spectra counts for Fam108b1 in DMSO control samples.21Integer
272Standard Deviation [DMSO control, Fam108b1]Standard deviation for the average number of spectra counts for Fam108b1 in DMSO control samples.21Float
273Ratio Average Spectra Counts [Fam108b1]Ratio of average number of spectra counts in test compound treated samples over DMSO control samples.21Floatratio
274Outcome [Apeh]One of Active, Inactive, or Not Tested.22Acylpeptide hydrolase [Mus musculus]Outcome
275Spectra Counts [1] [Apeh] (1μM**)Number of spectra counts for Apeh in test compound treated sample, replicate 1.22Integer
276Spectra Counts [2] [Apeh] (1μM**)Number of spectra counts for Apeh in test compound treated sample, replicate 2.22Integer
277Spectra Counts [3] [Apeh] (1μM**)Number of spectra counts for Apeh in test compound treated sample, replicate 3.22Integer
278Spectra Counts [4] [Apeh] (1μM**)Number of spectra counts for Apeh in test compound treated sample, replicate 4.22Integer
279Average Spectra Counts [Apeh] (1μM**)Average number of spectra counts for Apeh in test compound treated samples.22Integer
280Standard Deviation [Apeh]Standard Deviation for the average number of spectra counts for Apeh in test compound treated samples.22Float
281Spectra Counts [1] [DMSO control, Apeh]Number of spectra counts for Apeh in DMSO control sample, replicate 1.22Integer
282Spectra Counts [2] [DMSO control, Apeh]Number of spectra counts for Apeh in DMSO control sample, replicate 2.22Integer
283Spectra Counts [3] [DMSO control, Apeh]Number of spectra counts for Apeh in DMSO control sample, replicate 3.22Integer
284Average Spectra Counts [DMSO control, Apeh]Average number of spectra counts for Apeh in DMSO control samples.22Integer
285Standard Deviation [DMSO control, Apeh]Standard deviation for the average number of spectra counts for Apeh in DMSO control samples.22Float
286Ratio Average Spectra Counts [Apeh]Ratio of average number of spectra counts in test compound treated samples over DMSO control samples.22Floatratio
287Outcome [Abhd3]One of Active, Inactive, or Not Tested.23abhydrolase domain-containing protein 3 [Mus musculus]Outcome
288Spectra Counts [1] [Abhd3] (1μM**)Number of spectra counts for Abhd3 in test compound treated sample, replicate 1.23Integer
289Spectra Counts [2] [Abhd3] (1μM**)Number of spectra counts for Abhd3 in test compound treated sample, replicate 2.23Integer
290Spectra Counts [3] [Abhd3] (1μM**)Number of spectra counts for Abhd3 in test compound treated sample, replicate 3.23Integer
291Spectra Counts [4] [Abhd3] (1μM**)Number of spectra counts for Abhd3 in test compound treated sample, replicate 4.23Integer
292Average Spectra Counts [Abhd3] (1μM**)Average number of spectra counts for Abhd3 in test compound treated samples.23Integer
293Standard Deviation [Abhd3]Standard Deviation for the average number of spectra counts for Abhd3 in test compound treated samples.23Float
294Spectra Counts [1] [DMSO control, Abhd3]Number of spectra counts for Abhd3 in DMSO control sample, replicate 1.23Integer
295Spectra Counts [2] [DMSO control, Abhd3]Number of spectra counts for Abhd3 in DMSO control sample, replicate 2.23Integer
296Spectra Counts [3] [DMSO control, Abhd3]Number of spectra counts for Abhd3 in DMSO control sample, replicate 3.23Integer
297Average Spectra Counts [DMSO control, Abhd3]Average number of spectra counts for Abhd3 in DMSO control samples.23Integer
298Standard Deviation [DMSO control, Abhd3]Standard deviation for the average number of spectra counts for Abhd3 in DMSO control samples.23Float
299Ratio Average Spectra Counts [Abhd3]Ratio of average number of spectra counts in test compound treated samples over DMSO control samples.23Floatratio
300Outcome [Abhd11]One of Active, Inactive, or Not Tested.24abhydrolase domain-containing protein 11 isoform 1 [Mus musculus]Outcome
301Spectra Counts [1] [Abhd11] (1μM**)Number of spectra counts for Abhd11 in test compound treated sample, replicate 1.24Integer
302Spectra Counts [2] [Abhd11] (1μM**)Number of spectra counts for Abhd11 in test compound treated sample, replicate 2.24Integer
303Spectra Counts [3] [Abhd11] (1μM**)Number of spectra counts for Abhd11 in test compound treated sample, replicate 3.24Integer
304Spectra Counts [4] [Abhd11] (1μM**)Number of spectra counts for Abhd11 in test compound treated sample, replicate 4.24Integer
305Average Spectra Counts [Abhd11] (1μM**)Average number of spectra counts for Abhd11 in test compound treated samples.24Integer
306Standard Deviation [Abhd11]Standard Deviation for the average number of spectra counts for Abhd11 in test compound treated samples.24Float
307Spectra Counts [1] [DMSO control, Abhd11]Number of spectra counts for Abhd11 in DMSO control sample, replicate 1.24Integer
308Spectra Counts [2] [DMSO control, Abhd11]Number of spectra counts for Abhd11 in DMSO control sample, replicate 2.24Integer
309Spectra Counts [3] [DMSO control, Abhd11]Number of spectra counts for Abhd11 in DMSO control sample, replicate 3.24Integer
310Average Spectra Counts [DMSO control, Abhd11]Average number of spectra counts for Abhd11 in DMSO control samples.24Integer
311Standard Deviation [DMSO control, Abhd11]Standard deviation for the average number of spectra counts for Abhd11 in DMSO control samples.24Float
312Ratio Average Spectra Counts [Abhd11]Ratio of average number of spectra counts in test compound treated samples over DMSO control samples.24Floatratio
313Outcome [Abhd4]One of Active, Inactive, or Not Tested.25abhydrolase domain-containing protein 4 isoform 1 [Mus musculus]Outcome
314Spectra Counts [1] [Abhd4] (1μM**)Number of spectra counts for Abhd4 in test compound treated sample, replicate 1.25Integer
315Spectra Counts [2] [Abhd4] (1μM**)Number of spectra counts for Abhd4 in test compound treated sample, replicate 2.25Integer
316Spectra Counts [3] [Abhd4] (1μM**)Number of spectra counts for Abhd4 in test compound treated sample, replicate 3.25Integer
317Spectra Counts [4] [Abhd4] (1μM**)Number of spectra counts for Abhd4 in test compound treated sample, replicate 4.25Integer
318Average Spectra Counts [Abhd4] (1μM**)Average number of spectra counts for Abhd4 in test compound treated samples.25Integer
319Standard Deviation [Abhd4]Standard Deviation for the average number of spectra counts for Abhd4 in test compound treated samples.25Float
320Spectra Counts [1] [DMSO control, Abhd4]Number of spectra counts for Abhd4 in DMSO control sample, replicate 1.25Integer
321Spectra Counts [2] [DMSO control, Abhd4]Number of spectra counts for Abhd4 in DMSO control sample, replicate 2.25Integer
322Spectra Counts [3] [DMSO control, Abhd4]Number of spectra counts for Abhd4 in DMSO control sample, replicate 3.25Integer
323Average Spectra Counts [DMSO control, Abhd4]Average number of spectra counts for Abhd4 in DMSO control samples.25Integer
324Standard Deviation [DMSO control, Abhd4]Standard deviation for the average number of spectra counts for Abhd4 in DMSO control samples.25Float
325Ratio Average Spectra Counts [Abhd4]Ratio of average number of spectra counts in test compound treated samples over DMSO control samples.25Floatratio
326Outcome [Pla2g15]One of Active, Inactive, or Not Tested.26group XV phospholipase A2 precursor [Mus musculus]Outcome
327Spectra Counts [1] [Pla2g15] (1μM**)Number of spectra counts for Pla2g15 in test compound treated sample, replicate 1.26Integer
328Spectra Counts [2] [Pla2g15] (1μM**)Number of spectra counts for Pla2g15 in test compound treated sample, replicate 2.26Integer
329Spectra Counts [3] [Pla2g15] (1μM**)Number of spectra counts for Pla2g15 in test compound treated sample, replicate 3.26Integer
330Spectra Counts [4] [Pla2g15] (1μM**)Number of spectra counts for Pla2g15 in test compound treated sample, replicate 4.26Integer
331Average Spectra Counts [Pla2g15] (1μM**)Average number of spectra counts for Pla2g15 in test compound treated samples.26Integer
332Standard Deviation [Pla2g15]Standard Deviation for the average number of spectra counts for Pla2g15 in test compound treated samples.26Float
333Spectra Counts [1] [DMSO control, Pla2g15]Number of spectra counts for Pla2g15 in DMSO control sample, replicate 1.26Integer
334Spectra Counts [2] [DMSO control, Pla2g15]Number of spectra counts for Pla2g15 in DMSO control sample, replicate 2.26Integer
335Spectra Counts [3] [DMSO control, Pla2g15]Number of spectra counts for Pla2g15 in DMSO control sample, replicate 3.26Integer
336Average Spectra Counts [DMSO control, Pla2g15]Average number of spectra counts for Pla2g15 in DMSO control samples.26Integer
337Standard Deviation [DMSO control, Pla2g15]Standard deviation for the average number of spectra counts for Pla2g15 in DMSO control samples.26Float
338Ratio Average Spectra Counts [Pla2g15]Ratio of average number of spectra counts in test compound treated samples over DMSO control samples.26Floatratio
339Outcome [Fam108a]One of Active, Inactive, or Not Tested.27abhydrolase domain-containing protein FAM108A precursor [Mus musculus]Outcome
340Spectra Counts [1] [Fam108a] (1μM**)Number of spectra counts for Fam108a in test compound treated sample, replicate 1.27Integer
341Spectra Counts [2] [Fam108a] (1μM**)Number of spectra counts for Fam108a in test compound treated sample, replicate 2.27Integer
342Spectra Counts [3] [Fam108a] (1μM**)Number of spectra counts for Fam108a in test compound treated sample, replicate 3.27Integer
343Spectra Counts [4] [Fam108a] (1μM**)Number of spectra counts for Fam108a in test compound treated sample, replicate 4.27Integer
344Average Spectra Counts [Fam108a] (1μM**)Average number of spectra counts for Fam108a in test compound treated samples.27Integer
345Standard Deviation [Fam108a]Standard Deviation for the average number of spectra counts for Fam108a in test compound treated samples.27Float
346Spectra Counts [1] [DMSO control, Fam108a]Number of spectra counts for Fam108a in DMSO control sample, replicate 1.27Integer
347Spectra Counts [2] [DMSO control, Fam108a]Number of spectra counts for Fam108a in DMSO control sample, replicate 2.27Integer
348Spectra Counts [3] [DMSO control, Fam108a]Number of spectra counts for Fam108a in DMSO control sample, replicate 3.27Integer
349Average Spectra Counts [DMSO control, Fam108a]Average number of spectra counts for Fam108a in DMSO control samples.27Integer
350Standard Deviation [DMSO control, Fam108a]Standard deviation for the average number of spectra counts for Fam108a in DMSO control samples.27Float
351Ratio Average Spectra Counts [Fam108a]Ratio of average number of spectra counts in test compound treated samples over DMSO control samples.27Floatratio
352Outcome [Fam108c1]One of Active, Inactive, or Not Tested.28abhydrolase domain-containing protein FAM108C1 [Mus musculus]Outcome
353Spectra Counts [1] [Fam108c1] (1μM**)Number of spectra counts for Fam108c1 in test compound treated sample, replicate 1.28Integer
354Spectra Counts [2] [Fam108c1] (1μM**)Number of spectra counts for Fam108c1 in test compound treated sample, replicate 2.28Integer
355Spectra Counts [3] [Fam108c1] (1μM**)Number of spectra counts for Fam108c1 in test compound treated sample, replicate 3.28Integer
356Spectra Counts [4] [Fam108c1] (1μM**)Number of spectra counts for Fam108c1 in test compound treated sample, replicate 4.28Integer
357Average Spectra Counts [Fam108c1] (1μM**)Average number of spectra counts for Fam108c1 in test compound treated samples.28Integer
358Standard Deviation [Fam108c1]Standard Deviation for the average number of spectra counts for Fam108c1 in test compound treated samples.28Float
359Spectra Counts [1] [DMSO control, Fam108c1]Number of spectra counts for Fam108c1 in DMSO control sample, replicate 1.28Integer
360Spectra Counts [2] [DMSO control, Fam108c1]Number of spectra counts for Fam108c1 in DMSO control sample, replicate 2.28Integer
361Spectra Counts [3] [DMSO control, Fam108c1]Number of spectra counts for Fam108c1 in DMSO control sample, replicate 3.28Integer
362Average Spectra Counts [DMSO control, Fam108c1]Average number of spectra counts for Fam108c1 in DMSO control samples.28Integer
363Standard Deviation [DMSO control, Fam108c1]Standard deviation for the average number of spectra counts for Fam108c1 in DMSO control samples.28Float
364Ratio Average Spectra Counts [Fam108c1]Ratio of average number of spectra counts in test compound treated samples over DMSO control samples.28Floatratio
365Outcome [Rbbp9]One of Active, Inactive, or Not Tested.29putative hydrolase RBBP9 [Mus musculus]Outcome
366Spectra Counts [1] [Rbbp9] (1μM**)Number of spectra counts for Rbbp9 in test compound treated sample, replicate 1.29Integer
367Spectra Counts [2] [Rbbp9] (1μM**)Number of spectra counts for Rbbp9 in test compound treated sample, replicate 2.29Integer
368Spectra Counts [3] [Rbbp9] (1μM**)Number of spectra counts for Rbbp9 in test compound treated sample, replicate 3.29Integer
369Spectra Counts [4] [Rbbp9] (1μM**)Number of spectra counts for Rbbp9 in test compound treated sample, replicate 4.29Integer
370Average Spectra Counts [Rbbp9] (1μM**)Average number of spectra counts for Rbbp9 in test compound treated samples.29Integer
371Standard Deviation [Rbbp9]Standard Deviation for the average number of spectra counts for Rbbp9 in test compound treated samples.29Float
372Spectra Counts [1] [DMSO control, Rbbp9]Number of spectra counts for Rbbp9 in DMSO control sample, replicate 1.29Integer
373Spectra Counts [2] [DMSO control, Rbbp9]Number of spectra counts for Rbbp9 in DMSO control sample, replicate 2.29Integer
374Spectra Counts [3] [DMSO control, Rbbp9]Number of spectra counts for Rbbp9 in DMSO control sample, replicate 3.29Integer
375Average Spectra Counts [DMSO control, Rbbp9]Average number of spectra counts for Rbbp9 in DMSO control samples.29Integer
376Standard Deviation [DMSO control, Rbbp9]Standard deviation for the average number of spectra counts for Rbbp9 in DMSO control samples.29Float
377Ratio Average Spectra Counts [Rbbp9]Ratio of average number of spectra counts in test compound treated samples over DMSO control samples.29Floatratio
378Outcome [Lactb]One of Active, Inactive, or Not Tested.30serine beta-lactamase-like protein LACTB, mitochondrial precursor [Mus musculus]Outcome
379Spectra Counts [1] [Lactb] (1μM**)Number of spectra counts for Lactb in test compound treated sample, replicate 1.30Integer
380Spectra Counts [2] [Lactb] (1μM**)Number of spectra counts for Lactb in test compound treated sample, replicate 2.30Integer
381Spectra Counts [3] [Lactb] (1μM**)Number of spectra counts for Lactb in test compound treated sample, replicate 3.30Integer
382Spectra Counts [4] [Lactb] (1μM**)Number of spectra counts for Lactb in test compound treated sample, replicate 4.30Integer
383Average Spectra Counts [Lactb] (1μM**)Average number of spectra counts for Lactb in test compound treated samples.30Integer
384Standard Deviation [Lactb]Standard Deviation for the average number of spectra counts for Lactb in test compound treated samples.30Float
385Spectra Counts [1] [DMSO control, Lactb]Number of spectra counts for Lactb in DMSO control sample, replicate 1.30Integer
386Spectra Counts [2] [DMSO control, Lactb]Number of spectra counts for Lactb in DMSO control sample, replicate 2.30Integer
387Spectra Counts [3] [DMSO control, Lactb]Number of spectra counts for Lactb in DMSO control sample, replicate 3.30Integer
388Average Spectra Counts [DMSO control, Lactb]Average number of spectra counts for Lactb in DMSO control samples.30Integer
389Standard Deviation [DMSO control, Lactb]Standard deviation for the average number of spectra counts for Lactb in DMSO control samples.30Float
390Ratio Average Spectra Counts [Lactb]Ratio of average number of spectra counts in test compound treated samples over DMSO control samples.30Floatratio
391Outcome [Acot7]One of Active, Inactive, or Not Tested.31cytosolic acyl coenzyme A thioester hydrolase isoform 1 [Mus musculus]Outcome
392Spectra Counts [1] [Acot7] (1μM**)Number of spectra counts for Acot7 in test compound treated sample, replicate 1.31Integer
393Spectra Counts [2] [Acot7] (1μM**)Number of spectra counts for Acot7 in test compound treated sample, replicate 2.31Integer
394Spectra Counts [3] [Acot7] (1μM**)Number of spectra counts for Acot7 in test compound treated sample, replicate 3.31Integer
395Spectra Counts [4] [Acot7] (1μM**)Number of spectra counts for Acot7 in test compound treated sample, replicate 4.31Integer
396Average Spectra Counts [Acot7] (1μM**)Average number of spectra counts for Acot7 in test compound treated samples.31Integer
397Standard Deviation [Acot7]Standard Deviation for the average number of spectra counts for Acot7 in test compound treated samples.31Float
398Spectra Counts [1] [DMSO control, Acot7]Number of spectra counts for Acot7 in DMSO control sample, replicate 1.31Integer
399Spectra Counts [2] [DMSO control, Acot7]Number of spectra counts for Acot7 in DMSO control sample, replicate 2.31Integer
400Spectra Counts [3] [DMSO control, Acot7]Number of spectra counts for Acot7 in DMSO control sample, replicate 3.31Integer
401Average Spectra Counts [DMSO control, Acot7]Average number of spectra counts for Acot7 in DMSO control samples.31Integer
402Standard Deviation [DMSO control, Acot7]Standard deviation for the average number of spectra counts for Acot7 in DMSO control samples.31Float
403Ratio Average Spectra Counts [Acot7]Ratio of average number of spectra counts in test compound treated samples over DMSO control samples.31Floatratio
404Outcome [Pnpla6]One of Active, Inactive, or Not Tested.32neuropathy target esterase [Mus musculus]Outcome
405Spectra Counts [1] [Pnpla6] (1μM**)Number of spectra counts for Pnpla6 in test compound treated sample, replicate 1.32Integer
406Spectra Counts [2] [Pnpla6] (1μM**)Number of spectra counts for Pnpla6 in test compound treated sample, replicate 2.32Integer
407Spectra Counts [3] [Pnpla6] (1μM**)Number of spectra counts for Pnpla6 in test compound treated sample, replicate 3.32Integer
408Spectra Counts [4] [Pnpla6] (1μM**)Number of spectra counts for Pnpla6 in test compound treated sample, replicate 4.32Integer
409Average Spectra Counts [Pnpla6] (1μM**)Average number of spectra counts for Pnpla6 in test compound treated samples.32Integer
410Standard Deviation [Pnpla6]Standard Deviation for the average number of spectra counts for Pnpla6 in test compound treated samples.32Float
411Spectra Counts [1] [DMSO control, Pnpla6]Number of spectra counts for Pnpla6 in DMSO control sample, replicate 1.32Integer
412Spectra Counts [2] [DMSO control, Pnpla6]Number of spectra counts for Pnpla6 in DMSO control sample, replicate 2.32Integer
413Spectra Counts [3] [DMSO control, Pnpla6]Number of spectra counts for Pnpla6 in DMSO control sample, replicate 3.32Integer
414Average Spectra Counts [DMSO control, Pnpla6]Average number of spectra counts for Pnpla6 in DMSO control samples.32Integer
415Standard Deviation [DMSO control, Pnpla6]Standard deviation for the average number of spectra counts for Pnpla6 in DMSO control samples.32Float
416Ratio Average Spectra Counts [Pnpla6]Ratio of average number of spectra counts in test compound treated samples over DMSO control samples.32Floatratio
417Outcome [Dpp9]One of Active, Inactive, or Not Tested.33dipeptidyl peptidase 9 [Mus musculus]Outcome
418Spectra Counts [1] [Dpp9] (1μM**)Number of spectra counts for Dpp9 in test compound treated sample, replicate 1.33Integer
419Spectra Counts [2] [Dpp9] (1μM**)Number of spectra counts for Dpp9 in test compound treated sample, replicate 2.33Integer
420Spectra Counts [3] [Dpp9] (1μM**)Number of spectra counts for Dpp9 in test compound treated sample, replicate 3.33Integer
421Spectra Counts [4] [Dpp9] (1μM**)Number of spectra counts for Dpp9 in test compound treated sample, replicate 4.33Integer
422Average Spectra Counts [Dpp9] (1μM**)Average number of spectra counts for Dpp9 in test compound treated samples.33Integer
423Standard Deviation [Dpp9]Standard Deviation for the average number of spectra counts for Dpp9 in test compound treated samples.33Float
424Spectra Counts [1] [DMSO control, Dpp9]Number of spectra counts for Dpp9 in DMSO control sample, replicate 1.33Integer
425Spectra Counts [2] [DMSO control, Dpp9]Number of spectra counts for Dpp9 in DMSO control sample, replicate 2.33Integer
426Spectra Counts [3] [DMSO control, Dpp9]Number of spectra counts for Dpp9 in DMSO control sample, replicate 3.33Integer
427Average Spectra Counts [DMSO control, Dpp9]Average number of spectra counts for Dpp9 in DMSO control samples.33Integer
428Standard Deviation [DMSO control, Dpp9]Standard deviation for the average number of spectra counts for Dpp9 in DMSO control samples.33Float
429Ratio Average Spectra Counts [Dpp9]Ratio of average number of spectra counts in test compound treated samples over DMSO control samples.33Floatratio
430Outcome [Tpp2]One of Active, Inactive, or Not Tested.34Tpp2 protein [Mus musculus]Outcome
431Spectra Counts [1] [Tpp2] (1μM**)Number of spectra counts for Tpp2 in test compound treated sample, replicate 1.34Integer
432Spectra Counts [2] [Tpp2] (1μM**)Number of spectra counts for Tpp2 in test compound treated sample, replicate 2.34Integer
433Spectra Counts [3] [Tpp2] (1μM**)Number of spectra counts for Tpp2 in test compound treated sample, replicate 3.34Integer
434Spectra Counts [4] [Tpp2] (1μM**)Number of spectra counts for Tpp2 in test compound treated sample, replicate 4.34Integer
435Average Spectra Counts [Tpp2] (1μM**)Average number of spectra counts for Tpp2 in test compound treated samples.34Integer
436Standard Deviation [Tpp2]Standard Deviation for the average number of spectra counts for Tpp2 in test compound treated samples.34Float
437Spectra Counts [1] [DMSO control, Tpp2]Number of spectra counts for Tpp2 in DMSO control sample, replicate 1.34Integer
438Spectra Counts [2] [DMSO control, Tpp2]Number of spectra counts for Tpp2 in DMSO control sample, replicate 2.34Integer
439Spectra Counts [3] [DMSO control, Tpp2]Number of spectra counts for Tpp2 in DMSO control sample, replicate 3.34Integer
440Average Spectra Counts [DMSO control, Tpp2]Average number of spectra counts for Tpp2 in DMSO control samples.34Integer
441Standard Deviation [DMSO control, Tpp2]Standard deviation for the average number of spectra counts for Tpp2 in DMSO control samples.34Float
442Ratio Average Spectra Counts [Tpp2]Ratio of average number of spectra counts in test compound treated samples over DMSO control samples.34Floatratio
443Outcome [Pafah1b3]One of Active, Inactive, or Not Tested.35platelet-activating factor acetylhydrolase IB subunit gamma [Mus musculus]Outcome
444Spectra Counts [1] [Pafah1b3] (1μM**)Number of spectra counts for Pafah1b3 in test compound treated sample, replicate 1.35Integer
445Spectra Counts [2] [Pafah1b3] (1μM**)Number of spectra counts for Pafah1b3 in test compound treated sample, replicate 2.35Integer
446Spectra Counts [3] [Pafah1b3] (1μM**)Number of spectra counts for Pafah1b3 in test compound treated sample, replicate 3.35Integer
447Spectra Counts [4] [Pafah1b3] (1μM**)Number of spectra counts for Pafah1b3 in test compound treated sample, replicate 4.35Integer
448Average Spectra Counts [Pafah1b3] (1μM**)Average number of spectra counts for Pafah1b3 in test compound treated samples.35Integer
449Standard Deviation [Pafah1b3]Standard Deviation for the average number of spectra counts for Pafah1b3 in test compound treated samples.35Float
450Spectra Counts [1] [DMSO control, Pafah1b3]Number of spectra counts for Pafah1b3 in DMSO control sample, replicate 1.35Integer
451Spectra Counts [2] [DMSO control, Pafah1b3]Number of spectra counts for Pafah1b3 in DMSO control sample, replicate 2.35Integer
452Spectra Counts [3] [DMSO control, Pafah1b3]Number of spectra counts for Pafah1b3 in DMSO control sample, replicate 3.35Integer
453Average Spectra Counts [DMSO control, Pafah1b3]Average number of spectra counts for Pafah1b3 in DMSO control samples.35Integer
454Standard Deviation [DMSO control, Pafah1b3]Standard deviation for the average number of spectra counts for Pafah1b3 in DMSO control samples.35Float
455Ratio Average Spectra Counts [Pafah1b3]Ratio of average number of spectra counts in test compound treated samples over DMSO control samples.35Floatratio
456Outcome [Dpp8]One of Active, Inactive, or Not Tested.36dipeptidyl peptidase 8 [Mus musculus]Outcome
457Spectra Counts [1] [Dpp8] (1μM**)Number of spectra counts for Dpp8 in test compound treated sample, replicate 1.36Integer
458Spectra Counts [2] [Dpp8] (1μM**)Number of spectra counts for Dpp8 in test compound treated sample, replicate 2.36Integer
459Spectra Counts [3] [Dpp8] (1μM**)Number of spectra counts for Dpp8 in test compound treated sample, replicate 3.36Integer
460Spectra Counts [4] [Dpp8] (1μM**)Number of spectra counts for Dpp8 in test compound treated sample, replicate 4.36Integer
461Average Spectra Counts [Dpp8] (1μM**)Average number of spectra counts for Dpp8 in test compound treated samples.36Integer
462Standard Deviation [Dpp8]Standard Deviation for the average number of spectra counts for Dpp8 in test compound treated samples.36Float
463Spectra Counts [1] [DMSO control, Dpp8]Number of spectra counts for Dpp8 in DMSO control sample, replicate 1.36Integer
464Spectra Counts [2] [DMSO control, Dpp8]Number of spectra counts for Dpp8 in DMSO control sample, replicate 2.36Integer
465Spectra Counts [3] [DMSO control, Dpp8]Number of spectra counts for Dpp8 in DMSO control sample, replicate 3.36Integer
466Average Spectra Counts [DMSO control, Dpp8]Average number of spectra counts for Dpp8 in DMSO control samples.36Integer
467Standard Deviation [DMSO control, Dpp8]Standard deviation for the average number of spectra counts for Dpp8 in DMSO control samples.36Float
468Ratio Average Spectra Counts [Dpp8]Ratio of average number of spectra counts in test compound treated samples over DMSO control samples.36Floatratio
469Outcome [Lyplal1]One of Active, Inactive, or Not Tested.37acyl-protein thioesterase 1 [Mus musculus]Outcome
470Spectra Counts [1] [Lyplal1] (1μM**)Number of spectra counts for Lyplal1 in test compound treated sample, replicate 1.37Integer
471Spectra Counts [2] [Lyplal1] (1μM**)Number of spectra counts for Lyplal1 in test compound treated sample, replicate 2.37Integer
472Spectra Counts [3] [Lyplal1] (1μM**)Number of spectra counts for Lyplal1 in test compound treated sample, replicate 3.37Integer
473Spectra Counts [4] [Lyplal1] (1μM**)Number of spectra counts for Lyplal1 in test compound treated sample, replicate 4.37Integer
474Average Spectra Counts [Lyplal1] (1μM**)Average number of spectra counts for Lyplal1 in test compound treated samples.37Integer
475Standard Deviation [Lyplal1]Standard Deviation for the average number of spectra counts for Lyplal1 in test compound treated samples.37Float
476Spectra Counts [1] [DMSO control, Lyplal1]Number of spectra counts for Lyplal1 in DMSO control sample, replicate 1.37Integer
477Spectra Counts [2] [DMSO control, Lyplal1]Number of spectra counts for Lyplal1 in DMSO control sample, replicate 2.37Integer
478Spectra Counts [3] [DMSO control, Lyplal1]Number of spectra counts for Lyplal1 in DMSO control sample, replicate 3.37Integer
479Average Spectra Counts [DMSO control, Lyplal1]Average number of spectra counts for Lyplal1 in DMSO control samples.37Integer
480Standard Deviation [DMSO control, Lyplal1]Standard deviation for the average number of spectra counts for Lyplal1 in DMSO control samples.37Float
481Ratio Average Spectra Counts [Lyplal1]Ratio of average number of spectra counts in test compound treated samples over DMSO control samples.37Floatratio
482Outcome [Lipe]One of Active, Inactive, or Not Tested.38hormone-sensitive lipase isoform 2 [Mus musculus]Outcome
483Spectra Counts [1] [Lipe] (1μM**)Number of spectra counts for Lipe in test compound treated sample, replicate 1.38Integer
484Spectra Counts [2] [Lipe] (1μM**)Number of spectra counts for Lipe in test compound treated sample, replicate 2.38Integer
485Spectra Counts [3] [Lipe] (1μM**)Number of spectra counts for Lipe in test compound treated sample, replicate 3.38Integer
486Spectra Counts [4] [Lipe] (1μM**)Number of spectra counts for Lipe in test compound treated sample, replicate 4.38Integer
487Average Spectra Counts [Lipe] (1μM**)Average number of spectra counts for Lipe in test compound treated samples.38Integer
488Standard Deviation [Lipe]Standard Deviation for the average number of spectra counts for Lipe in test compound treated samples.38Float
489Spectra Counts [1] [DMSO control, Lipe]Number of spectra counts for Lipe in DMSO control sample, replicate 1.38Integer
490Spectra Counts [2] [DMSO control, Lipe]Number of spectra counts for Lipe in DMSO control sample, replicate 2.38Integer
491Spectra Counts [3] [DMSO control, Lipe]Number of spectra counts for Lipe in DMSO control sample, replicate 3.38Integer
492Average Spectra Counts [DMSO control, Lipe]Average number of spectra counts for Lipe in DMSO control samples.38Integer
493Standard Deviation [DMSO control, Lipe]Standard deviation for the average number of spectra counts for Lipe in DMSO control samples.38Float
494Ratio Average Spectra Counts [Lipe]Ratio of average number of spectra counts in test compound treated samples over DMSO control samples.38Floatratio
495Outcome [Es1]One of Active, Inactive, or Not Tested.39liver carboxylesterase N precursor [Mus musculus]Outcome
496Spectra Counts [1] [Es1] (1μM**)Number of spectra counts for Es1 in test compound treated sample, replicate 1.39Integer
497Spectra Counts [2] [Es1] (1μM**)Number of spectra counts for Es1 in test compound treated sample, replicate 2.39Integer
498Spectra Counts [3] [Es1] (1μM**)Number of spectra counts for Es1 in test compound treated sample, replicate 3.39Integer
499Spectra Counts [4] [Es1] (1μM**)Number of spectra counts for Es1 in test compound treated sample, replicate 4.39Integer
500Average Spectra Counts [Es1] (1μM**)Average number of spectra counts for Es1 in test compound treated samples.39Integer
501Standard Deviation [Es1]Standard Deviation for the average number of spectra counts for Es1 in test compound treated samples.39Float
502Spectra Counts [1] [DMSO control, Es1]Number of spectra counts for Es1 in DMSO control sample, replicate 1.39Integer
503Spectra Counts [2] [DMSO control, Es1]Number of spectra counts for Es1 in DMSO control sample, replicate 2.39Integer
504Spectra Counts [3] [DMSO control, Es1]Number of spectra counts for Es1 in DMSO control sample, replicate 3.39Integer
505Average Spectra Counts [DMSO control, Es1]Average number of spectra counts for Es1 in DMSO control samples.39Integer
506Standard Deviation [DMSO control, Es1]Standard deviation for the average number of spectra counts for Es1 in DMSO control samples.39Float
507Ratio Average Spectra Counts [Es1]Ratio of average number of spectra counts in test compound treated samples over DMSO control samples.39Floatratio
508Outcome [Acot3]One of Active, Inactive, or Not Tested.40acyl-coenzyme A thioesterase 3 [Mus musculus]Outcome
509Spectra Counts [1] [Acot3] (1μM**)Number of spectra counts for Acot3 in test compound treated sample, replicate 1.40Integer
510Spectra Counts [2] [Acot3] (1μM**)Number of spectra counts for Acot3 in test compound treated sample, replicate 2.40Integer
511Spectra Counts [3] [Acot3] (1μM**)Number of spectra counts for Acot3 in test compound treated sample, replicate 3.40Integer
512Spectra Counts [4] [Acot3] (1μM**)Number of spectra counts for Acot3 in test compound treated sample, replicate 4.40Integer
513Average Spectra Counts [Acot3] (1μM**)Average number of spectra counts for Acot3 in test compound treated samples.40Integer
514Standard Deviation [Acot3]Standard Deviation for the average number of spectra counts for Acot3 in test compound treated samples.40Float
515Spectra Counts [1] [DMSO control, Acot3]Number of spectra counts for Acot3 in DMSO control sample, replicate 1.40Integer
516Spectra Counts [2] [DMSO control, Acot3]Number of spectra counts for Acot3 in DMSO control sample, replicate 2.40Integer
517Spectra Counts [3] [DMSO control, Acot3]Number of spectra counts for Acot3 in DMSO control sample, replicate 3.40Integer
518Average Spectra Counts [DMSO control, Acot3]Average number of spectra counts for Acot3 in DMSO control samples.40Integer
519Standard Deviation [DMSO control, Acot3]Standard deviation for the average number of spectra counts for Acot3 in DMSO control samples.40Float
520Ratio Average Spectra Counts [Acot3]Ratio of average number of spectra counts in test compound treated samples over DMSO control samples.40Floatratio
521Outcome [Prcp]One of Active, Inactive, or Not Tested.41lysosomal Pro-X carboxypeptidase precursor [Mus musculus]Outcome
522Spectra Counts [1] [Prcp] (1μM**)Number of spectra counts for Prcp in test compound treated sample, replicate 1.41Integer
523Spectra Counts [2] [Prcp] (1μM**)Number of spectra counts for Prcp in test compound treated sample, replicate 2.41Integer
524Spectra Counts [3] [Prcp] (1μM**)Number of spectra counts for Prcp in test compound treated sample, replicate 3.41Integer
525Spectra Counts [4] [Prcp] (1μM**)Number of spectra counts for Prcp in test compound treated sample, replicate 4.41Integer
526Average Spectra Counts [Prcp] (1μM**)Average number of spectra counts for Prcp in test compound treated samples.41Integer
527Standard Deviation [Prcp]Standard Deviation for the average number of spectra counts for Prcp in test compound treated samples.41Float
528Spectra Counts [1] [DMSO control, Prcp]Number of spectra counts for Prcp in DMSO control sample, replicate 1.41Integer
529Spectra Counts [2] [DMSO control, Prcp]Number of spectra counts for Prcp in DMSO control sample, replicate 2.41Integer
530Spectra Counts [3] [DMSO control, Prcp]Number of spectra counts for Prcp in DMSO control sample, replicate 3.41Integer
531Average Spectra Counts [DMSO control, Prcp]Average number of spectra counts for Prcp in DMSO control samples.41Integer
532Standard Deviation [DMSO control, Prcp]Standard deviation for the average number of spectra counts for Prcp in DMSO control samples.41Float
533Ratio Average Spectra Counts [Prcp]Ratio of average number of spectra counts in test compound treated samples over DMSO control samples.41Floatratio
534Outcome [Parl]One of Active, Inactive, or Not Tested.42presenilins-associated rhomboid-like protein, mitochondrial precursor [Mus musculus]Outcome
535Spectra Counts [1] [Parl] (1μM**)Number of spectra counts for Parl in test compound treated sample, replicate 1.42Integer
536Spectra Counts [2] [Parl] (1μM**)Number of spectra counts for Parl in test compound treated sample, replicate 2.42Integer
537Spectra Counts [3] [Parl] (1μM**)Number of spectra counts for Parl in test compound treated sample, replicate 3.42Integer
538Spectra Counts [4] [Parl] (1μM**)Number of spectra counts for Parl in test compound treated sample, replicate 4.42Integer
539Average Spectra Counts [Parl] (1μM**)Average number of spectra counts for Parl in test compound treated samples.42Integer
540Standard Deviation [Parl]Standard Deviation for the average number of spectra counts for Parl in test compound treated samples.42Float
541Spectra Counts [1] [DMSO control, Parl]Number of spectra counts for Parl in DMSO control sample, replicate 1.42Integer
542Spectra Counts [2] [DMSO control, Parl]Number of spectra counts for Parl in DMSO control sample, replicate 2.42Integer
543Spectra Counts [3] [DMSO control, Parl]Number of spectra counts for Parl in DMSO control sample, replicate 3.42Integer
544Average Spectra Counts [DMSO control, Parl]Average number of spectra counts for Parl in DMSO control samples.42Integer
545Standard Deviation [DMSO control, Parl]Standard deviation for the average number of spectra counts for Parl in DMSO control samples.42Float
546Ratio Average Spectra Counts [Parl]Ratio of average number of spectra counts in test compound treated samples over DMSO control samples.42Floatratio
547Outcome [Acot6]One of Active, Inactive, or Not Tested.43acyl-coenzyme A thioesterase 6 [Mus musculus]Outcome
548Spectra Counts [1] [Acot6] (1μM**)Number of spectra counts for Acot6 in test compound treated sample, replicate 1.43Integer
549Spectra Counts [2] [Acot6] (1μM**)Number of spectra counts for Acot6 in test compound treated sample, replicate 2.43Integer
550Spectra Counts [3] [Acot6] (1μM**)Number of spectra counts for Acot6 in test compound treated sample, replicate 3.43Integer
551Spectra Counts [4] [Acot6] (1μM**)Number of spectra counts for Acot6 in test compound treated sample, replicate 4.43Integer
552Average Spectra Counts [Acot6] (1μM**)Average number of spectra counts for Acot6 in test compound treated samples.43Integer
553Standard Deviation [Acot6]Standard Deviation for the average number of spectra counts for Acot6 in test compound treated samples.43Float
554Spectra Counts [1] [DMSO control, Acot6]Number of spectra counts for Acot6 in DMSO control sample, replicate 1.43Integer
555Spectra Counts [2] [DMSO control, Acot6]Number of spectra counts for Acot6 in DMSO control sample, replicate 2.43Integer
556Spectra Counts [3] [DMSO control, Acot6]Number of spectra counts for Acot6 in DMSO control sample, replicate 3.43Integer
557Average Spectra Counts [DMSO control, Acot6]Average number of spectra counts for Acot6 in DMSO control samples.43Integer
558Standard Deviation [DMSO control, Acot6]Standard deviation for the average number of spectra counts for Acot6 in DMSO control samples.43Float
559Ratio Average Spectra Counts [Acot6]Ratio of average number of spectra counts in test compound treated samples over DMSO control samples.43Floatratio

** Test Concentration. § Panel component ID.
Additional Information
Grant Number: 1R01HL084366

Classification
PageFrom: